fbpx
Anuh Pharma – Multibagger Analysis

Anuh Pharma – Multibagger Analysis

One of the leading manufacturers of Active Pharmaceutical Ingredients (API’s). Registered in 1960, the company has grown several folds and earned recognition besides gaining the trust of a strong customer base. Today it is one of the largest producers of macrolides in the country.image

Company URL: http://www.anuhpharma.com/

Screener URL: http://www.screener.in/company/506260

CMP: 316

Warren Buffett Checklist

History of Consistently Increasing Sales, Earnings & Cash FlowYes.image
Durable Competitive Advantage Claims as largest produce of macrolides in the country.image
Future Growth DriversModerate.image
Conservative Debt (long term debt < 3 Net Profit)Yes.image
Debt Equity Ratio, Current Ratio0. Impressive.image
Return on Equity must be Above Average21%.image
Low CAPEX required to maintain current operationsModerate.image
Management is holding / buying the stock65%. Slightly increasing over years.image
Price is Under Valued (< intrinsic value)Moderate.image
Stock Price is consolidating (now)Yes.image
Stock Price is growing in past years along with EPS growthYes.image

Additional Futurecaps Checklist

Consolidated PE, PB RatioPE 15, PB 3image
Cash Flow Positive, Net Profit % greater than 8%Yes. Yes.image
Paying Dividends, TaxYes. Yes.image
EPS Growth Rate30% in latest year.image
Jump in Trailing ResultsYes.image
Quarterly Results GrowingYes. 50% above.image
Expected Gain in 5 YearsConsidering the growth of 40% as standard, the company should give 8-10 times in 5 years.image
Price Movement Graph, 52 Week High & Low3x difference only.image
Volume AnalysisLow volume. Good.image
Power of BrandModerate.image
Corporate Governance, Reputation of LeadersYes. image
Fraud reportedNot in current search. image

Declaration

Considering the above qualities, we declare the stock as a potential  multibagger.

image_thumb1

Allocation

2-3% of your portfolio.

Disclaimer

Futurecaps recommends 20 to 25 multibaggers per year, we recommend a 25% to 50% allocation of your savings in equity.  The stocks recommended here are gone through Analysts of several years experience in stock market.  Although they were successful in predicting future multibaggers, the overall stock market is a risky game.  So we recommend the reader to put his/her own thoughts & invest wisely.

About Futurecaps

Futurecaps is a 12+ year experienced Indian Stock Market Advisory with SEBI Registration.

NEVER MISS our 5-Paid-Multibaggers which are Hand-picked using Warren Buffet strategies!

3 Replies to “Anuh Pharma – Multibagger Analysis”

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: